[HTML][HTML] MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?

O Brunetti, A Russo, A Scarpa, D Santini, M Reni… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDAC) is a tumor with a poor prognosis, short overall
survival and few chemotherapeutic choices. MicroRNAs (miRNAs) are non-coding, single …

MicroRNAs as regulators and effectors of hematopoietic transcription factors

MJ Kim, CI Civin, TJ Kingsbury - Wiley Interdisciplinary Reviews …, 2019 - Wiley Online Library
Hematopoiesis is a highly‐regulated development process orchestrated by lineage‐specific
transcription factors that direct the generation of all mature blood cells types, including red …

[PDF][PDF] Profiling of circulating serum microRNAs in children with autism spectrum disorder using stem-loop qRT-PCR assay

TM Kichukova, NT Popov, IS Ivanov, TI Vachev - Folia medica, 2017 - archive.sciendo.com
Background: Development of biomarkers for autism spectrum disorder (ASD) has still
remained a challenge to date. Recently, alterations of the expression of microRNAs …

The multifaceted role and utility of microRNAs in indolent B-cell non-Hodgkin lymphomas

PI Artemaki, PA Letsos, IC Zoupa, K Katsaraki… - Biomedicines, 2021 - mdpi.com
Normal B-cell development is a tightly regulated complex procedure, the deregulation of
which can lead to lymphomagenesis. One common group of blood cancers is the B-cell non …

miRNAs and radiotherapy response in prostate cancer

MY Konoshenko, OE Bryzgunova, PP Laktionov - Andrology, 2021 - Wiley Online Library
Background Gaining insight into microRNAs (miRNAs) and genes that regulate the
therapeutic response of cancer diseases in general and prostate cancer (PCa) in particular …

High-throughput microRNA profiling of vitreoretinal lymphoma: vitreous and serum microRNA profiles distinct from uveitis

T Minezaki, Y Usui, M Asakage, M Takanashi… - Journal of Clinical …, 2020 - mdpi.com
Purpose: Vitreoretinal lymphoma (VRL) is a non-Hodgkin lymphoma of the diffuse large B
cell type (DLBCL), which is an aggressive cancer causing central nervous system related …

miRNA profile at diagnosis predicts treatment outcome in patients with B-chronic lymphocytic leukemia: A FILO study

I Duroux-Richard, AL Gagez, E Alaterre… - Frontiers in …, 2022 - frontiersin.org
During many years, chemo-immunotherapy fludarabine-cyclophosphamide-rituximab (FCR)
was the gold standard for first line treatment of medically fit patients with symptomatic B …

Cross-talk between Myc and p53 in B-cell lymphomas

L Yu, TT Yu, KH Young - Chronic diseases and translational …, 2019 - mednexus.org
Myc and p53 proteins are closely associated with many physiological cellular functions,
including immune response and lymphocyte survival, and are expressed in the lymphoid …

Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms

M Braoudaki, GI Lambrou, K Giannikou… - Journal of hematology & …, 2014 - Springer
Background Although, substantial experimental evidence related to diagnosis and treatment
of pediatric central nervous system (CNS) neoplasms have been demonstrated, the …

MicroRNA-33a disturbs influenza A virus replication by targeting ARCN1 and inhibiting viral ribonucleoprotein activity

Y Hu, L Jiang, W Lai, Y Qin… - Journal of General …, 2016 - microbiologyresearch.org
In order to explore the roles of microRNA (s)[miRNA (s)] in the influenza A virus life cycle, we
compared the miRNA profiles of 293T and HeLa cell lines, as influenza A virus can replicate …